Concepedia

Publication | Open Access

S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial

DOIFull Paper Access

16

Citations

10

References

2019

Year

Ye Chen, Jing Wu, Ke Cheng, Zhiping Li, Deyun Luo, Meng Qiu, Hongfeng Gou, Cheng Yi, Qiu Li, Xin Wang,
The Oncologist

Abstract

S-1 combined with raltitrexed for refractory mCRC showed moderate effect, and it is worthy of further study as third- or later-line therapy in mCRC.

References

YearCitations

Page 1